"patients treated" trang 7 - tải miễn phí từ tailieunhanh
Comprehensive molecular and clinical characterization of Asian melanoma patients treated with anti-PD-1 antibody

Comprehensive molecular and clinical characterization of Asian melanoma patients treated with anti-PD-1 antibody
7    45    0
Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: A retrospective study

Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: A retrospective study
9    116    0
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy
8    78    0
Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy

Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy
8    34    0
Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: A retrospective study

Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: A retrospective study
10    63    0
Comparison of local tumor control in patients with HCC treated with SBRT or TACE: A propensity score analysis

Comparison of local tumor control in patients with HCC treated with SBRT or TACE: A propensity score analysis
9    89    0
Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
10    72    0
The long-term survival of patients with IIIIVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: A propensity score-matched analysis

The long-term survival of patients with IIIIVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: A propensity score-matched analysis
12    54    0
The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment

The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment
5    51    1
Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: A retrospective cohort study

Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: A retrospective cohort study
9    39    1
Risk of second primary cancers in cancer patients treated with cisplatin: A systematic review and meta-analysis of randomized studies

Risk of second primary cancers in cancer patients treated with cisplatin: A systematic review and meta-analysis of randomized studies
12    52    1
Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization

Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization
9    37    1
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT
9    68    1
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
7    61    1
Prediction of 5–year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods

Prediction of 5–year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods
9    74    1
Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy

Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy
10    40    1
Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer

Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer
9    77    1
The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression

The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression
8    61    1
Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: A multicenter randomized controlled trial

Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: A multicenter randomized controlled trial
9    62    1
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing firstline gemcitabine-containing therapy: Effect of performance status and comparison with other regimens

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing firstline gemcitabine-containing therapy: Effect of performance status and comparison with other regimens
9    70    1